dafabet live casino

Entering the foot-and-mouth disease inactivated vaccine workshop of Jinyu Biotechnology Co., Ltd. located in Hohhot Economic and Technological Development Zone，Staff wearing protective clothing are shuttling between large and small metal tanks。“Jinyu Biotech conquered the large-scale cell suspension culture technology and thousand-fold purification and concentration process in 2008，Become the leading company participating in the formulation of national foot-and-mouth disease vaccine quality testing standards。Currently，Jinyu Biotechnology’s market share in the foot-and-mouth disease vaccine market has exceeded 40%。”Introduced by Xing Rui, the company’s workshop manager，The products developed by the company cover pigs、Cow、Sheep、poultry、More than 110 vaccines and more than 40 diagnostic reagents in 5 categories for pets，Covering the national market and exporting to surrounding countries and regions。As of now，Jinyu Biotech has 3 national laboratories、6 R&D platforms and the world’s first intelligent animal vaccine manufacturing factory and the world’s first mRNA animal vaccine production line。

Jinyu Biotechnology Co., Ltd. shows strong core competitiveness，Is a vivid portrayal of the high-quality cultivation of biomedical industry clusters in Hohhot。In recent years，Hohhot City through the deep integration of technological innovation and industrial innovation，Keep an eye on key projects，Continuously promote the high-end biomedical industry、dafabet live casinoIntelligent、Going green，The development of biomedical industry clusters has achieved remarkable results。First half of this year，Hohhot’s biomedical industry cluster continues to maintain strong development momentum，Achieved cumulative industrial output value 90.3.4 billion yuan，Accounting for 7% of the city’s total industrial output value.05%，Laid a solid foundation for achieving full-year goals。

The outstanding results were achieved thanks to the smooth advancement of a series of key projects。First half of this year，The biomedical industry cluster has implemented a total of 31 key projects，22 new projects among them、9 continuation projects，A total of 14 investments completed.100 million yuan。These projects cover animal vaccines、Biological fermentation and pharmaceuticals、Multiple subdivisions such as traditional Chinese medicine，Provides strong support for the comprehensive development of the biomedical industry。

In the construction of key projects，Jinyu Baoling Biological Annual Production 2.2.8 billion ml animal mRNA vaccine and nucleic acid drug project、Jinyu Gyori Pet Vaccine Project、Ketuo animal and plant microecological preparation production base project has been completed and put into operation，Not only improves the production capacity of Hohhot’s biomedical industry，It also further consolidated its leading position in the industry。At the same time，Changsheng Pharmaceutical 5 billion amoxicillin capsules、Shuangqi Pharmaceutical Bio-intelligent Manufacturing Industrial Park、Puze Bio-Probiotics Industrial Park and other projects have started construction，It also laid the foundation for the sustainable development of the biomedical industry in the future。

In addition to promoting key projects，Hohhot City also provides investment promotion and policy support，Continuously attract high-quality biopharmaceutical companies at home and abroad。2023，Published "Ten Measures for Hohhot dafabet online sports betting appto Support the High-quality Development of the Biomedical Industry"，A total of 35 key projects in the biomedical industry were implemented throughout the year，Total investment 95.3.9 billion yuan。Implementation of these measures，Provides a more superior policy environment for biopharmaceutical companies，Attracting more and more biomedical companies to settle in Hohhot。First half of this year，22 newly signed projects in the biomedical industry cluster，The investment amount reaches 17.9.3 billion yuan。Among them，Guoxin Medical R&D Project、Yihe Bencao Chinese and Mongolian medicinal materials R&D and operation base project、Wanrui Biological Products High-tech Industrialization Project Phase II and other 9 projects have started，Injecting new vitality into the further development of the biomedical industry cluster。

Hohhot City actively promotes the deep integration of biomedical industry and technological innovation，Sitting in the National Engineering Laboratory of Veterinary Vaccines、Key Laboratory of Ruminant Biological Products, Ministry of Agriculture and Rural Affairs、Three national key laboratories of high-level biosafety laboratories，Continuously improving basic research and technological innovation capabilities in the field of biomedicine。At the same time，Hohhot City strengthens cooperation with universities inside and outside the district、Cooperation with scientific research institutes，Establish an industrial science and technology innovation consortium，Jointly promote the innovative development of the biomedical industry。Under the guidance of technological innovation，Hohhot’s biomedical industry cluster is getting ready for development，Towards higher quality、Moving towards higher-level development goals。

According to the latest plan，Hohhot City will focus on biological vaccines、Biological fermentation and pharmaceuticals、Traditional Chinese medicine and other subdivisions，Further optimize industrial layout，Enhance dafabet online betting websitethe potential for high-quality development。Future，Hohhot is expected to become a first-class biological vaccine research and development base in China、A complete chain of biofermentation and pharmaceutical transformation and upgrading demonstration base and a distinctive traditional Chinese medicine (Mongolian medicine) inheritance and development base，Inject strong impetus into the prosperity and development of regional economy。

Ready to take off，Sail away。current，Hohhot is committed to building a green biopharmaceutical industry base in northern China，Make full use of the advantages of the biomedical industry，Accelerate the transformation and industrialization of new achievements，Continue to improve the development level of the biomedical industry，The “wave” of competition for new industry tracks。

Source: Hohhot Daily